Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization (Q45376156)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 May 2010

Language	Label	Description	Also known as
English	Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization	scientific article published on 6 May 2010

Statements

scholarly article

1 reference

Europe PubMed Central

13 December 2017

Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization (English)

1 reference

Europe PubMed Central

13 December 2017

1 reference

based on heuristic

inferred from title

hepatitis E virus

object named as

hepatitis E virus

1 reference

based on heuristic

inferred from title

author name string

Shucai Yang

1

1 reference

Europe PubMed Central

13 December 2017

Chunling Wang

2

1 reference

Europe PubMed Central

13 December 2017

Xuefeng Fang

3

1 reference

Europe PubMed Central

13 December 2017

Lijie Zhai

4

1 reference

Europe PubMed Central

13 December 2017

Chen Dong

5

1 reference

Europe PubMed Central

13 December 2017

Lei Ding

6

1 reference

Europe PubMed Central

13 December 2017

Jihong Meng

7

1 reference

Europe PubMed Central

13 December 2017

Lixin Wang

8

1 reference

Europe PubMed Central

13 December 2017

publication date

6 May 2010

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

151

1 reference

Europe PubMed Central

13 December 2017

2

1 reference

Europe PubMed Central

13 December 2017

162-169

1 reference

Europe PubMed Central

13 December 2017

Genetic variability of hepatitis E virus within and between three epidemics in India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Epidemiology of hepatitis E: current status

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Locally acquired hepatitis E virus infection, El Paso, Texas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986–1988) of China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Sequence comparison of the capsid region of hepatitis E viruses isolated from Myanmar and China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

High Mortality Associated with an Outbreak of Hepatitis E among Displaced Persons in Darfur, Sudan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

C3d enhancement of neutralizing antibodies to measles hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Seroepidemiology of hepatitis E virus in patients with non-A, non-B, non-C hepatitis in Hungary

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

DNA vaccination against hepatitis E virus infection in cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Infection of a Japanese patient by genotype 4 hepatitis e virus while traveling in Vietnam.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

The effect of antigen targeting sequences on antibody responses to hepatitis E virus DNA vaccines in rats and sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

A genotype IV hepatitis E virus strain that may be indigenous to Changchun, China.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E in the south west of France in individuals who have never visited an endemic area

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Identification and characterization of the neutralization epitope(s) of the hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Identification of genotype 3 hepatitis E virus in fecal samples from a pig farm located in a Shanghai suburb

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

UK acquired hepatitis E--An emerging problem?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E outbreak on cruise ship.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Genetic heterogeneity of hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Overview of Hepatitis E Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Identification of a genotype III swine hepatitis E virus that was isolated from a Japanese pig born in 1990 and that is most closely related to Japanese isolates of human hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Development and evaluation of an efficient cell-culture system for Hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Contribution of C3d-P28 repeats to enhancement of immune responses against HBV-preS2/S induced by gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E: an overview and recent advances in vaccine research.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Enhancement of humoral immunity to the hCG beta protein antigen by fusing a molecular adjuvant C3d3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Prevalence of four different subgenotypes of genotype 4 hepatitis E virus among swine in the Shanghai area of China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E virus genotyping based on full-length genome and partial genomic regions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Identification of two neutralization epitopes on the capsid protein of avian hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

A new PCR-based seroneutralization assay in cell culture for diagnosis of hepatitis E

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIRUSRES.2010.04.011

1 reference

Europe PubMed Central

13 December 2017

1 reference

Europe PubMed Central

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45376156&oldid=2076250486"